NCT00006475View on ClinicalTrials.gov

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2000

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Leukemia

Interventions

DRUG

imatinib mesylate

Trial Locations (1)

07936

Novartis Pharmaceuticals Corporation, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY